Medical Weight Loss Treatment for South Dakota Residents
Medically Supervised Weight Loss, Delivered Online
Our providers are licensed by the South Dakota Board of Medical and Osteopathic Examiners for statewide telehealth services.
Whether you're in Sioux Falls, Pierre, or anywhere across South Dakota — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in South Dakota
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
From the Black Hills to the Badlands, Sioux Falls' growing metro to the ranches of the plains, South Dakota's natural beauty deserves healthcare to match. OmniRx Health serves the entire Mount Rushmore State—connecting residents across its vast landscape with expert medical care. When the nearest specialist is hours away across the prairie, our telehealth platform ensures you still have access to personalized, quality healthcare from the comfort of home.
Available Treatments in South Dakota
Our board-certified providers in South Dakota can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in South Dakota
State Licensing
Our providers are licensed by the South Dakota Board of Medical and Osteopathic Examiners for statewide telehealth services.
Telehealth Law
South Dakota's telehealth regulations support virtual care delivery while ensuring patient safety across its vast geography.
Pharmacy Access
South Dakota pharmacies in Sioux Falls, Rapid City, and throughout the state provide prescription services with reliable delivery.
Insurance Notes
South Dakota insurers cover telehealth services, recognizing virtual care's essential role in serving the state's rural population.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in South Dakota
Explore Related Medical Weight Loss Pages
Direct links to specific treatments and other states.